Social Media Posts Promoted Unnecessary Alzheimer's Tests
Researchers found many viral posts marketed blood-based Alzheimer's biomarker tests to healthy individuals.
Updated on Sept. 20, 2026 in Alzheimer’s
Live Poll
Do you trust health information found on social media for personal medical screening decisions?
A study published in the Journal of the American Geriatrics Society revealed that social media accounts frequently promote Alzheimer's blood-based biomarker tests for asymptomatic people. These posts, which reached a combined 114 million followers, raise concerns about the misuse of diagnostic testing.
Why it matters
The findings highlight the risks of medical misinformation online, as accounts with financial interests are significantly more likely to target healthy users for tests they may not clinically require.
Researchers analyzed 188 social media posts across Facebook, Instagram, and TikTok that identify brain changes via biomarkers like p-tau217 and p-tau181. Online providers currently charge between $365 and $600 for these tests.
The players
University of Sydney
This academic institution led the research team that conducted the social media analysis.
Journal of the American Geriatrics Society
This peer-reviewed publication serves as the venue for the study regarding biomarker test marketing.
The details
The analysis indicates that approximately 10 percent of the posts originated from doctors, with most of these being based in the United States. While testing through an Australian doctor costs up to $400, the broader availability of online options complicates the diagnostic landscape.
Timeline
The study findings were published on September 20, 2026.
Health Landscape
This study underscores the growing tension between rapid diagnostic innovation and the clinical diagnostic criteria for Alzheimer's disease. The widespread marketing of blood-based biomarkers marks a shift toward consumer-driven diagnostics that often bypass traditional clinical oversight.
Patients should be cautious of online advertisements for Alzheimer's testing that target healthy individuals without professional medical advice. Always consult a primary care physician before pursuing expensive biomarker tests to ensure they are clinically appropriate for your specific health situation.
The takeaway
Consumers should view online medical testing offers with skepticism, particularly when the provider stands to profit from the sale. Prioritizing evidence-based guidance from established medical practitioners remains the safest approach for neurological health assessments.
Further reading
For more information on the diagnostic landscape for the disease, visit the Alzheimer’s section.
Live Poll
Do you trust health information found on social media for personal medical screening decisions?
